David W. Anstice

Mr. Anstice most recently served as Executive Vice President of Merck & Co., Inc. from 2006 to 2008 with responsibility for enterprise strategy and implementation. During separate parts of this period, he served as acting President, Global Human Health and as President of Merck’s business in Japan. From 2003 to 2006, Mr. Anstice served as President of Merck, with responsibility for Merck’s Asia Pacific businesses. In his 34 years with Merck, Mr. Anstice held a variety of positions with their worldwide ventures, including President, U.S. Human Health; President, U.S./Canada; President, Human Health, the Americas; and President, Human Health, Europe. Mr. Anstice is an Adjunct Professor at the University of Sydney Business School and serves as a member of the Board of Directors at the University of Sydney USA Foundation. He is also a non-executive Director of NeuClone Pharmaceuticals Pty. Ltd and previously served as a non-executive Director of CSL Limited.

Back to Leadership page